|
DBN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.727400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.748600E-01 |
| Normal-vs-Stage2 |
3.113600E-01 |
| Normal-vs-Stage3 |
2.451000E-01 |
| Normal-vs-Stage4 |
9.005200E-01 |
| Stage1-vs-Stage2 |
2.923600E-02 |
| Stage1-vs-Stage3 |
4.821800E-01 |
| Stage1-vs-Stage4 |
5.803400E-01 |
| Stage2-vs-Stage3 |
4.515700E-02 |
| Stage2-vs-Stage4 |
4.875000E-01 |
| Stage3-vs-Stage4 |
3.784400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.193800E-01 |
| Normal-vs-AfricanAmerican |
6.795400E-01 |
| Normal-vs-Asian |
8.277000E-01 |
| Caucasian-vs-AfricanAmerican |
6.498400E-01 |
| Caucasian-vs-Asian |
6.314400E-01 |
| AfricanAmerican-vs-Asian |
6.527400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.848000E-01 |
| Normal-vs-Female |
1.127380E-01 |
| Male-vs-Female |
2.567800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.987000E-01 |
| Normal-vs-Extreme_Weight |
5.470000E-01 |
| Normal-vs-Obese |
6.576000E-01 |
| Normal-vs-Extreme_Obese |
2.645400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.009800E-01 |
| Normal_Weight-vs-Obese |
6.062200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.289200E-01 |
| Extreme_Weight-vs-Obese |
9.089600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.133800E-01 |
| Obese-vs-Extreme_Obese |
4.507600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.975620E-01 |
| Normal-vs-Age(41-60Yrs) |
2.108200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.944600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.889700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.190400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.828170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.882300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.723600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.996000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.120500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.575600E-01 |
| Normal-VS-Type2 PRCC |
4.834800E-01 |
| Normal-VS-KIRP CIMP |
4.794600E-01 |
| Normal-VS-Unclassified PRCC |
2.155200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.070070E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.308400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.923600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.757400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.757700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.484400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.470200E-01 |
| Normal-vs-N1 |
2.351800E-01 |
| Normal-vs-N2 |
4.451400E-01 |
| N0-vs-N1 |
2.654500E-02 |
| N0-vs-N2 |
5.871700E-02 |
| N1-vs-N2 |
5.176800E-01 |
|
|
